FDA advisers dismiss safety warnings, back four peptide treatments
A panel of outside advisers to the U.S. Food and Drug Administration (FDA) voted Thursday to let specialized pharmacies produce and sell four peptide treatments the agency banned three years ago.
Jul 24, 2026
0
12
